Regulation of breast cancer resistant protein by peroxisome proliferator-activated receptor α in human brain microvessel endothelial cells

Molecular Pharmacology

Volumn 81, Issue 4, 2012, Pages 598-609

  Hoque, Md Tozammel ^a   Robillard, Kevin R ^a   Bendayan, Reina ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; ABC TRANSPORTER; BREAST CANCER RESISTANCE PROTEIN; CLOFIBRATE; CYCLOPHILIN B; MESSENGER RNA; MITOXANTRONE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; SMALL INTERFERING RNA;

ARTICLE; BINDING KINETICS; BIOACCUMULATION; BIOAVAILABILITY; BLOOD BRAIN BARRIER; BRAIN BLOOD VESSEL; BRAIN NERVE CELL; BRAIN TISSUE; CELL MEMBRANE; CHROMATIN IMMUNOPRECIPITATION; CONCENTRATION (PARAMETERS); CONFOCAL MICROSCOPY; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; ENZYME SUBSTRATE; FETUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IN VITRO STUDY; LIPID METABOLISM; MICROVASCULATURE; NEUROPROTECTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

ATP-BINDING CASSETTE TRANSPORTERS; BASE SEQUENCE; BIOLOGICAL AVAILABILITY; BLOOD-BRAIN BARRIER; BRAIN; CELL LINE, TRANSFORMED; CHROMATIN IMMUNOPRECIPITATION; DNA PRIMERS; ENDOTHELIUM, VASCULAR; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MICROVESSELS; NEOPLASM PROTEINS; PPAR ALPHA; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84858754598     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.111.076745     Document Type: Article

References (42)

1. Abbott NJ, Patabendige AA, Dolman DE, Yusof SR, and Begley DJ (2010) Structure and function of the blood-brain barrier. Neurobiol Dis 37:13-25.
2. Bauer B, Hartz AM, Fricker G, and Miller DS (2004) Pregnane X receptor up-regulation of P-glycoprotein expression and transport function at the blood-brain barrier. Mol Pharmacol 66:413-419. (Pubitemid 39329239)
3. Bauer B, Yang X, Hartz AM, Olson ER, Zhao R, Kalvass JC, Pollack GM, and Miller DS (2006) In vivo activation of human pregnane X receptor tightens the blood-brain barrier to methadone through P-glycoprotein up-regulation. Mol Pharmacol 70:1212-1219. (Pubitemid 44435972)
4. Benani A, Krémarik-Bouillaud P, Bianchi A, Netter P, Minn A, and Dauça M (2003) Evidence for the presence of both peroxisome proliferator-activated receptors alpha and beta in the rat spinal cord. J Chem Neuroanat 25:29-38. (Pubitemid 36164853)
5. Bendayan R, Lee G, and Bendayan M (2002) Functional expression and localization of P-glycoprotein at the blood brain barrier. Microsc Res Tech 57:365-380. (Pubitemid 34579217)
6. Bendayan R, Ronaldson PT, Gingras D, and Bendayan M (2006) In situ localization of P-glycoprotein (ABCB1) in human and rat brain. J Histochem Cytochem 54:1159-1167. (Pubitemid 44434719)
7. Bright JJ, Kanakasabai S, Chearwae W, and Chakraborty S (2008) PPAR regulation of inflammatory signaling in CNS diseases. PPAR Res 2008:658520.
8. Chan GN, Hoque MT, Cummins CL, and Bendayan R (2011) Regulation of P-glycoprotein by orphan nuclear receptors in human brain microvessel endothelial cells. J Neurochem 118:163-175.
9. Cullingford TE, Bhakoo K, Peuchen S, Dolphin CT, Patel R, and Clark JB (1998) Distribution of mRNAs encoding the peroxisome proliferator-activated receptor alpha, beta, and gamma and the retinoid X receptor alpha, beta, and gamma in rat central nervous system. J Neurochem 70:1366-1375. (Pubitemid 28136948)
10. Dauchy S, Dutheil F, Weaver RJ, Chassoux F, Daumas-Duport C, Couraud PO, Scherrmann JM, De Waziers I, and Declèves X (2008) ABC transporters, cytochromes P450 and their main transcription factors: expression at the human blood-brain barrier. J Neurochem 107:1518-1528.
11. Doyle LA, Yang W, Abruzzo LV, Krogmann T, Gao Y, Rishi AK, and Ross DD (1998) A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc Natl Acad Sci USA 95:15665-15670. (Pubitemid 29018757)
12. Enokizono J, Kusuhara H, Ose A, Schinkel AH, and Sugiyama Y (2008) Quantitative investigation of the role of breast cancer resistance protein (Bcrp/Abcg2) in limiting brain and testis penetration of xenobiotic compounds. Drug Metab Dispos 36:995-1002. (Pubitemid 351717455)
13. Enokizono J, Kusuhara H, and Sugiyama Y (2007) Effect of breast cancer resistance protein (Bcrp/Abcg2) on the disposition of phytoestrogens. Mol Pharmacol 72:967-975. (Pubitemid 47481419)
14. Goto T, Lee JY, Teraminami A, Kim YI, Hirai S, Uemura T, Inoue H, Takahashi N, and Kawada T (2011) Activation of peroxisome proliferator-activated receptoralpha stimulates both differentiation and fatty acid oxidation in adipocytes. J Lipid Res 52:873-884.
15. Hartz AM, Mahringer A, Miller DS, and Bauer B (2010) 17-β-Estradiol: a powerful modulator of blood-brain barrier BCRP activity. J Cereb Blood Flow Metab 30:1742-1755.
16. Hirai T, Fukui Y, and Motojima K (2007) PPARalpha agonists positively and negatively regulate the expression of several nutrient/drug transporters in mouse small intestine. Biol Pharm Bull 30:2185-2190. (Pubitemid 350097033)
17. Hoque MT and Ishikawa F (2001) Human chromatid cohesin component hRad21 is phosphorylated in m phase and associated with metaphase centromeres. J Biol Chem 276:5059-5067. (Pubitemid 33650059)
18. Huang W, Eum SY, András IE, Hennig B, and Toborek M (2009) PPARalpha and PPARgamma attenuate HIV-induced dysregulation of tight junction proteins by modulations of matrix metalloproteinase and proteasome activities. FASEB J 23:1596-1606.
19. Huang W, Rha GB, Han MJ, Eum SY, András IE, Zhong Y, Hennig B, and Toborek M (2008) PPARalpha and PPARgamma effectively protect against HIV-induced inflammatory responses in brain endothelial cells. J Neurochem 107:497-509.
20. Ishikawa T (2009) The role of human ABC transporter ABCG2 (BCRP) in pharmacotherapy. Adv Drug Deliv Rev 61:1-2.
21. Kehrer JP, Biswal SS, La E, Thuillier P, Datta K, Fischer SM, and Vanden Heuvel JP (2001) Inhibition of peroxisome-proliferator-activated receptor (PPAR)alpha by MK886. Biochem J 356:899-906. (Pubitemid 32588464)
22. Kersten S, Desvergne B, and Wahli W (2000) Roles of PPARs in health and disease. Nature 405:421-424. (Pubitemid 30367411)
23. Lee G, Babakhanian K, Ramaswamy M, Prat A, Wosik K, and Bendayan R (2007) Expression of the ATP-binding cassette membrane transporter, ABCG2, in human and rodent brain microvessel endothelial and glial cell culture systems. Pharm Res 24:1262-1274. (Pubitemid 46870591)
24. Maliepaard M, Scheffer GL, Faneyte IF, van Gastelen MA, Pijnenborg AC, Schinkel AH, van De Vijver MJ, Scheper RJ, and Schellens JH (2001) Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. Cancer Res 61:3458-3464. (Pubitemid 32695041)
25. Miller DS (2010) Regulation of P-glycoprotein and other ABC drug transporters at the blood-brain barrier. Trends Pharmacol Sci 31:246-254.
26. Moffit JS, Aleksunes LM, Maher JM, Scheffer GL, Klaassen CD, and Manautou JE (2006) Induction of hepatic transporters multidrug resistance-associated proteins (Mrp) 3 and 4 by clofibrate is regulated by peroxisome proliferator-activated receptor alpha. J Pharmacol Exp Ther 317:537-545.
27. Muerhoff AS, Griffin KJ, and Johnson EF (1992) The peroxisome proliferator-activated receptor mediates the induction of CYP4A6, a cytochrome P450 fatty acid omega-hydroxylase, by clofibric acid. J Biol Chem 267:19051-19053.
28. Nagasawa M, Hara T, Kashino A, Akasaka Y, Ide T, and Murakami K (2009) Identification of a functional peroxisome proliferator-activated receptor (PPAR) response element (PPRE) in the human apolipoprotein A-IV gene. Biochem Pharmacol 78:523-530.
29. Pardridge WM (2010) Biopharmaceutical drug targeting to the brain. J Drug Target 18:157-167.
30. Polgar O, Robey RW, and Bates SE (2008) ABCG2: structure, function and role in drug response. Expert Opin Drug Metab Toxicol 4:1-15.
31. Robyr D, Wolffe AP, and Wahli W (2000) Nuclear hormone receptor coregulators in action: diversity for shared tasks. Mol Endocrinol 14:329-347. (Pubitemid 32266074)
32. Ronaldson PT, Ashraf T, and Bendayan R (2010) Regulation of multidrug resistance protein 1 by tumor necrosis factor alpha in cultured glial cells: involvement of nuclear factor-kappaB and C-Jun N-terminal kinase signaling pathways. Mol Pharmacol 77:644-659.
33. Ronaldson PT, Persidsky Y, and Bendayan R (2008) Regulation of ABC membrane transporters in glial cells: relevance to the pharmacotherapy of brain HIV-1 infection. Glia 56:1711-1735.
34. Schachtrup C, Emmler T, Bleck B, Sandqvist A, and Spener F (2004) Functional analysis of peroxisome-proliferator-responsive element motifs in genes of fatty acid-binding proteins. Biochem J 382:239-245. (Pubitemid 39141587)
35. Szatmari I, Vámosi G, Brazda P, Balint BL, Benko S, Széles L, Jeney V, Ozvegy- Laczka C, Szántó A, Barta E, et al. (2006) Peroxisome proliferator-activated receptor gamma-regulated ABCG2 expression confers cytoprotection to human dendritic cells. J Biol Chem 281:23812-23823. (Pubitemid 44274157)
36. Vlaming ML, Lagas JS, and Schinkel AH (2009) Physiological and pharmacological roles of ABCG2 (BCRP): recent findings in Abcg2 knockout mice. Adv Drug Deliv Rev 61:14-25.
37. Wang X, Hawkins BT, and Miller DS (2011) Aryl hydrocarbon receptor-mediated up-regulation of ATP-driven xenobiotic efflux transporters at the blood-brain barrier. FASEB J 25:644-652.
38. Wang X, Sykes DB, and Miller DS (2010) Constitutive androstane receptor-mediated up-regulation of ATP-driven xenobiotic efflux transporters at the blood-brain barrier. Mol Pharmacol 78:376-383.
39. Weksler BB, Subileau EA, Perrière N, Charneau P, Holloway K, Leveque M, Tricoire- Leignel H, Nicotra A, Bourdoulous S, Turowski P, et al. (2005) Blood-brain barrier-specific properties of a human adult brain endothelial cell line. FASEB J 19:1872-1874. (Pubitemid 41598779)
40. Woodland C, Huang TT, Gryz E, Bendayan R, and Fawcett JP (2008) Expression, activity and regulation of CYP3A in human and rodent brain. Drug Metab Rev 40:149-168. (Pubitemid 351220645)
41. Xu X, Otsuki M, Sumitani S, Saito H, Kouhara H, and Kasayama S (2002) RU486 antagonizes the inhibitory effect of peroxisome proliferator-activated receptor alpha on interleukin-6 production in vascular endothelial cells. J Steroid Biochem Mol Biol 81:141-146. (Pubitemid 34876405)
42. Zastre JA, Chan GN, Ronaldson PT, Ramaswamy M, Couraud PO, Romero IA, Weksler B, Bendayan M, and Bendayan R (2009) Up-regulation of P-glycoprotein by HIV protease inhibitors in a human brain microvessel endothelial cell line. J Neurosci Res 87:1023-1036.